Abstract-Non-motor symptoms, such as fear of falling and anxiety, are frequently reported in Parkinson's disease (PD). Recent evidence of anxiety and fear directly influencing balance control in healthy young and older adults, raises the question whether fear of falling and anxiety also directly contribute to the balance deficits observed in PD. The goal of the current study was to examine whether PD patients and controls responded similarly or differently to experimentally induced increases in anxiety. For this purpose, 14 PD patients (tested during a subjective optimal ON state) and 16 healthy age-matched control subjects stood in three conditions of different levels of postural threat: normal threat (quiet standing at ground level); medium threat (standing at the edge of a surface elevated to 80 cm); and high threat (same, but to 160 cm). Outcome measures included mean position, mean power of frequency (MPF) and root mean square (RMS) of centre of pressure (COP) displacements in the anterior-posterior (AP) and medial-lateral (ML) directions. Physiological and psychosocial measures of fear and anxiety were also recorded. Increased threat changed postural control similarly in PD patients and controls; MPF of AP and ML COP increased and the mean COP position was shifted backward in both groups. These results indicate that during the ON state, static balance in PD patients and controls is equally susceptible to the influence of anxiety. Significant correlations observed between COP changes and measures of fear and anxiety provide evidence to support the proposed neural links between structures controlling emotion and postural control. Future studies should further address this issue by including more severely affected patients, by testing the influence of dopaminergic medication, by including more anxious patients, and by using dynamic measures of balance.
Postural instability is a particularly disabling symptom in Parkinson's disease (PD) as it frequently leads to falls and injuries (Koller et al., 1989; Bloem et al., 2001) . Medical management of postural instability remains difficult (Bloem and Bhatia, 2004) , and development of improved therapies is hampered by lack of adequate pathophysiological insights. Careful assessment of the characteristics of postural control in PD is therefore a major issue for this patient population, as this provides the basis for rational development of improved treatment strategies tailored to specific contributing factors.
One way in which postural control is assessed in PD is to measure the characteristics of postural sway during periods of quiet stance. Sway is typically assessed by having subjects stand quietly on a forceplate, which records ground-reaction forces and moments that can be used to calculate the centre of pressure (COP), a weighted average of all forces acting beneath the feet (Winter et al., 1996) . The COP is considered the primary control variable responsible for restricting natural sway of the body's centre of mass (COM) and thus maintain equilibrium. The characteristics of the COP signal are usually quantified in terms of its mean position, amplitude and frequency of displacements in the anterior-posterior (AP) and medial-lateral (ML) directions, which are known to be controlled independently by the CNS (Winter et al., 1996) . Amplitude and frequency measures are used to describe the oscillatory nature of the COP signal which reflects the net neuromuscular response of the CNS to control the COM. Mean position of the COP reflects the average vertical projection of the COM during stance and therefore provides an indirect measure of leaning during stance.
While a number of prior studies have measured the characteristics of postural sway to investigate quiet standing performance in PD, the results have been inconsistent. For example, during quiet standing some investigators observed PD patients to have larger amplitudes of postural sway compared to age-matched controls (Mitchell et al., 1995; Contin et al., 1996; Rocchi et al., 2002; Maurer et al., 2003; Nardone and Schieppati, 2006; Błaszczyk et al., 2007) ; some have found no difference between the groups (Schieppati and Nardone, 1991; Termoz et al., 2008) ; while another found smaller postural sway in PD patients (Horak et al., 1992) . While studies have shown the frequency (or velocity) of COP displacements to be higher in PD patients compared to elderly controls (Rocchi et al., 2002; Maurer et al., 2003) , the changes in mean position are more variable; some studies have reported a forward shift in mean COP position in PD patients compared to elderly controls (Błaszczyk et al., 2007; Termoz et al., 2008) , while another has reported a more backward shift of mean COP in PD patients (Schieppati and Nardone, 1991) .
The potential origins of balance deficits in PD also remain largely unclear. Traditionally postural deficits have been attributed to disrupted dopaminergic pathways in the basal ganglia specifically responsible for processing motor commands. However, evidence is beginning to suggest that balance problems may not be solely attributable to the result of motor processing deficits in PD (Wright et al., 2010; Beckley et al., 1993; Brown et al., 2007) . Furthermore, while pharmacological and surgical treatments are highly successful in alleviating motor symptoms such as bradykinesia, stiffness and tremor, they often provide little to no improvement to postural control during quiet stance (Rocchi et al., 2002; Bloem and Bhatia, 2004; Bloem et al., 1996) . As such, attention has now started to shift to consider other non-motor functions within the basal ganglia as possible contributors to the development of postural deficits in PD.
Of the basal ganglia's non-motor functions, its role in emotional processing, has received the least consideration as a possible contributor to postural control. One of five parallel circuits within the basal ganglia, the limbic circuit is thought to be involved in higher-order processing of emotional information, and acts as a gate for widespread sources of emotional cues. Emotion is also commonly affected by PD. For example, between 28% and 38% of PD patients are diagnosed with clinical anxiety disorders according to Diagnostic and Statistical Manual of Mental Disorders III-R criteria (Stein et al., 1990; Menza et al., 1993) . Non-clinical anxiety is found in 20 -69% of PD patients (Aarsland et al., 1999; Kulisevsky et al., 2008) , while up to 45% of PD patients have a fear of falling (Bloem et al., 2001) . These rates are significantly higher than those reported for healthy elderly persons (Lyketsos et al., 2000; Bloem et al., 2001; Ritchie et al., 2004; Trollor et al., 2007; Geda et al., 2008) . Furthermore, PD patients have deficits in generating normal physiological and cortical responses to emotional or threatening stimuli (Yoshimura et al., 2005; Bowers et al., 2006; Tessitore et al., 2002) .
Interconnections between limbic and motor control circuitry within the basal ganglia, provide the means for the CNS to shape motor outputs based on the emotional context or meaning of a situation (Nakano, 2000) , and may explain the relationship observed between anxiety and motor symptom severity in patients with PD (Routh et al., 1987) . However, the question remains whether dysregulation of emotions, such as fear and anxiety, can also contribute to postural deficits associated with PD. The potential for anxiety to directly influence postural control has been recently demonstrated in healthy individuals. For example, studies have used elevated surface heights to directly investigate the effect of fear and anxiety on postural control in healthy young and older adult populations. The results of these studies suggest that standing on an increased surface height leads to changes in postural control, including a decrease of the amplitude and an increase of the frequency of AP COP displacements, as well as a backward displacement of the mean COP position (Carpenter et al., 1999 (Carpenter et al., , 2001a (Carpenter et al., , 2006 Adkin et al., 2000; Brown et al., 2006) . Whether such mechanisms are also at play in PD is much less clear. One study found that PD patients do not employ the same postural strategies as healthy controls when standing at or away from the edge of an elevated surface (Brown et al., 2007) . However, this study had several possible drawbacks: standing was measured for only very short time periods (15 s); changes in anxiety and fear were not verified experimentally; and it was step restriction as opposed to surface height that was used to manipulate postural threat.
Therefore, the aim of this study was to examine whether PD patients and controls would respond similarly to increases in postural threat. Based on earlier work (Brown et al., 2007) , we hypothesized that PD patients would not utilize the same postural strategies as healthy controls when standing on elevated surface heights.
EXPERIMENTAL PROCEDURES Participants
Fourteen subjects with PD and 16 healthy age-matched control subjects participated in the study (Tables 1 and 2 ). Each participant provided written informed consent prior to testing. The Hoehn and Yahr scale and motor examination subscale of the unified Parkinson's disease rating scale (UPDRS) were used to assess the severity of motor symptoms in PD patients. All participants completed a fall history and medical history survey, the mini mental state examination (MMSE) (Folstein et al., 1975) , and the frontal assessment battery (Dubois et al., 2000) . Because medication generally has little effect on postural control during quiet stance (Rocchi et al., 2002; Bloem and Bhatia, 2004; Bloem et al., 1996) , all PD patients were examined during their subjectively best ON clinical condition. Testing was timed to coincide with the expected time of each patient's subjectively best clinical condition, approximately 1 h after intake of their regular Parkinson medication (Tables 1 and 2 ). Participants were excluded if they had a medical condition other than PD that interfered with their balance, or had an MMSE score Ͻ24. Subjects were also excluded if they had an extreme fear of heights, a history of anxiety disorders or were taking any anti-anxiety medications. PD patients were excluded if they had a neurosurgical procedure for their PD, or when neurological examinations showed considerable postural tremor or significant dyskinesias that would influence the COP recordings. All experimental procedures were approved by the UBC Clinical Research Ethics Board.
Procedures
Subjects stood quietly in stocking feet on a forceplate (model #k00407, Bertec, USA) covered by a non-compliant rubber mat (0.5 cm thick) for a period of 120 s in four different conditions. The first condition was standing on ground level (normal condition), with the top surface of the forceplate located 9 cm above the ground. The second was a reduced threat condition which involved standing on ground level with additional safety features in place. However, this condition failed to elicit desired effects on reducing anxiety and increasing confidence in either group and was thus excluded from further analysis. The third condition was standing at the edge of a hydraulic platform elevated 80 cm above the ground (medium threat condition). The fourth was standing at the edge of the hydraulic platform elevated 160 cm above the ground (high threat condition). To ensure the safety of participants during the trials on the hydraulic platform, participants wore a safety harness which was securely fastened with rope to a support beam in a manner that did not interfere with their postural control. In all conditions a spotter stood behind the participants during the trial. The participants stood with their eyes open, arms hanging loosely by their sides and feet placed shoulder width apart during each trial. The foot position of the participants was marked on the forceplate to ensure that they returned to the same foot position in every trial. Participants were instructed to focus during the standing trial on a visual target placed at eye level approximately 3 m in front of them. A practice trial on ground level was performed first to allow participants to become familiarized with the procedures and remove any potential first trial effects (Adkin et al., 2000) . After the initial practice trial, participants performed a 2 min standing trial in the normal condition, followed by the reduced threat, medium threat and high threat condition, with a few minutes of seated rest in between each standing condition. The effect of postural threat on postural control is known to be influenced by order, with greater postural changes observed when participants stand in increasingly threatening, compared to less threatening, conditions (Adkin et al., 2000) . Based on this knowledge, the four conditions were presented in a fixed order across participants, to maximize the potential effect of threat, and thus provide the greatest opportunity to observe potential interactions with PD. Randomization would likely nullify the effect of threat on postural control, making potential interactions between groups and threat more difficult to discern.
Measurements
Several questionnaires were used to assess levels of anxiety, fear and balance confidence prior to testing, as well as before and after each standing trial. Prior to performing the practice trial, participants filled in the trait section of the state and trait anxiety inventory which uses a 4 point scale (from 1 (almost never) to 4 (almost always)) to rate 20 different statements referring to individual differences in the frequency and intensity with which anxiety man- ifests itself over time (Barnes et al., 2002) . Prior to each standing trial, participants rated how confident they were that they could maintain their balance and avoid a fall during the upcoming balance task on a scale from 0% (not confident at all) to 100% (completely confident). After each standing trial, participants rated how stable and how fearful of falling they felt during the trial, both on a scale from 0% (i.e. not stable/not fearful of falling) to 100% (i.e. completely stable/fearful of falling) (Hauck et al., 2008) . After each trial, participants also filled in the state anxiety questionnaire, which consists of 16 items rated on a scale from 1 (didn't feel at all) to 9 (felt this extremely) (Hauck et al., 2008) and the positive and negative affect schedule-expanded form (PANAS-X) fear subscale, where participants indicate the extent to which they feel (on a scale from 1 (not at all) to 5 (extremely)) about six words that describe different feelings and emotions (Watson and Clark, 1994) .
During the trials, participants' galvanic skin response (GSR) and ground reaction forces and moments were also recorded. GSR, a measure of physiological arousal, was recorded from electrodes placed on the thenar and hypothenar eminence of the participant's non-dominant hand (Critchley, 2002) . GSR measures were recorded at a sampling rate of 1 kHz and were smoothed off-line at a time constant of 0.2 s, prior to calculating the mean GSR over the entire 120 s trial. The mean GSR for each trial was normalized to the values recorded during the practice trial. Ground reaction forces and moments measured from the forceplate on which the participants stood were sampled at 100 Hz and low pass filtered offline using a 5 Hz dual-pass Butterworth filter, prior to calculating the COP in the AP and ML direction. The mean COP in the AP and ML directions was determined and removed from the signal prior to calculating the root mean square (RMS) and the mean power of frequency (MPF) of COP displacements.
Statistical analysis
Independent T-tests were performed to compare baseline clinical measures between controls and PD patients (Table 1 ). All dependent measures were analyzed using a 2ϫ3 between and within subject analysis of variance with threat (normal, medium and high) and group (controls and PD) as independent variables. Assumptions of normality and homogeneity of variances were examined and met across most dependent measures, variables and experimental conditions. Tests of assumptions were based on inspection of histograms and box-plots, and statistical tests of homogeneity. Levine's tests demonstrated equality of variances across groups for all measures (PϾ0.05). In the few cases where Box's M tests of equality of co-variance matrices (PϽ0.001) and/or Mauchly's tests of sphericity (PϽ0.05) were significant, the Greenhouse-Gueisser statistic was used. An overall ␣Ͻ0.05 was used for all statistical comparisons. In cases of significant main and interaction effects, post hoc comparisons were performed after adjusting for multiple comparisons using a Bonferroni correction (adjusted level of significanceϭ0.017). Differences between high threat and normal threat conditions were also calculated and used to examine associations between changes in psycho-social and GSR measures with changes in postural control using Pearson product moment correlations (PϽ0.05).
RESULTS
Manipulation of postural threat via changes in surface height resulted in significant changes in physiological and psychosocial indicators of arousal, anxiety and fear in both groups. There was a significant main effect of threat on the mean GSR level (F (1.664,46.580) ϭ18.696, PϽ0.001), with higher GSR levels observed in the medium and high threat conditions compared to the normal condition. A significant main effect of threat was observed for state-anxiety (F (2, 56) (F (2,56) ϭ9.626, PϽ0.001). Significantly higher scores of state-anxiety and fear were observed in the high threat condition compared to the normal and medium threat condition. Fear of falling for the high threat condition was significantly higher than for the normal condition. Balance confidence was significantly lower in the medium and high threat condition compared to the normal condition. Perceived stability was also significantly lower in the high threat condition compared to the normal condition, and medium threat condition. There was no significant main effect of group or interaction between threat and group on GSR or psychosocial measures (Fig. 1) .
Postural threat also had a significant influence on COP measures in both groups (Fig. 2) . There was a significant main effect of threat on the mean position of AP-COP (F (1.579,44.202) ϭ54.653, PϽ0.001). The mean position of AP-COP was shifted significantly backwards (away from the edge) in the medium and high threat conditions compared to the normal condition, and in the high threat compared to medium threat condition. There was also a significant main effect of threat on the MPF of COP in the AP (F (1.515,42.425) ϭ14.053, PϽ0.001) and ML direction (F (2,56) ϭ3.507, Pϭ0.037). AP-MPF in the medium and high threat conditions was significantly higher than in the normal condition, while there was a trend towards higher ML-MPF in the high threat condition than in the normal condition (Pϭ0.031). There was no significant main effect of threat on RMS of COP in the AP (F (2,56) ϭ1.494, Pϭ0.233) or ML direction (F (1.914,53.592) ϭ0.058, Pϭ0.938). For all COP measures there was no main effect of group or interaction between threat and group (Fig. 3) .
Across both groups, there was a significant positive correlation between changes in total anxiety and changes in MPF of COP in the AP (rϭ.391, Pϭ0.032) and ML directions (rϭ.424, Pϭ0.019). Likewise, there was a significant positive correlation between changes in the PANAS-X fear subscale and changes in RMS of COP in the AP direction (rϭ.441, Pϭ0.015) . No psychosocial or GSR changes were correlated to changes in mean COP position (PϾ0.05).
DISCUSSION

Postural threat influenced balance control in both PD patients and controls
The aim of this study was to examine whether patients and controls responded similarly to increases in postural threat. Brown and colleagues investigated whether PD patients alter their postural control of quiet standing in reaction to changes in environmental context (postural threat). They measured quiet standing in a low threat condition (0.6 m height with a wooden platform in front of the hydraulic lift to provide an opportunity to step forward) and a high threat condition (0.6 m height with the wooden platform removed). The results showed that PD patients manifested no changes in postural control during quiet standing with heightened postural threat, while controls showed a significant posterior shift of mean position of AP-COP and significant reduction in RMS amplitude of COP displacements. The authors concluded that PD patients have deficits in context-dependent regulation of quiet standing (Brown et al., 2007) . However, these results are inconsistent with the current observations of a posterior shift in mean position of AP-COP and increased MPF in the AP and ML direction in both PD patients and controls. Indeed, the current results indicate that PD patients can react to changes in threat level similar to controls. Although patient characteristics, including mean disease duration, the range in UPDRS motor scores and medications were very similar between the current study and that of Brown and colleagues, other differences are noteworthy. One important difference between the studies is that Brown and colleagues actually used step restriction, instead of surface height, to increase postural threat. It has been shown that surface height influences balance control during quiet stance independent of step restriction (Carpenter et al., 1999) . Furthermore, Brown and colleagues did not measure psychosocial or physiological indicators of anxiety or fear, in order to confirm the extent to which the manipulation of step restriction leads to changes in fear or anxiety. In contrast, the current study demonstrated that the manipulations of surface height were accompanied by significant changes in self-reported ratings of state anxiety, fear, balance confidence and perceived stability in both PD patients and controls. Furthermore changes in state anxiety and fear were found to be significantly correlated with changes in postural control across groups. Another important difference between studies was the time period used to collect COP measures during quiet stance. Brown and colleagues used a sampling duration of only 15 s, which is possibly too short to record reliable amplitude and frequency measures of postural control during quiet stance (Carpenter et al., 2001b) . In contrast, the current study sampled COP measures over 120 s of quiet stance, which exceeds the minimum time period required to ensure reliable and accurate measures of amplitude and frequency of COP displacements (Carpenter et al., 2001b) .
The significant relationships observed between fear and anxiety on postural control adds further support to the proposed neural link between areas of the brain controlling emotion, and areas responsible for balance control in humans (Balaban and Thayer, 2001) . In particular, the amygdala and associated limbic structures are central to the acquisition, modulation and expression of emotions, such as fear and anxiety, and have widespread efferent connections to areas involved in posture, including vestib- ular nuclei, the reticular formation, and nuclei within the basal ganglia and nucleus accumbens (Cardinal et al., 2002; Balaban and Thayer, 2001) .
Due to study limitations, the current results are unable to clarify the basal ganglia's role in mediating the effects of anxiety and fear on postural control. One such limitation was that participants were tested after they had taken their normal doses of Parkinson medication. Although dopaminergic medication generally has little effect on improving postural control, particularly during quiet stance (Rocchi et al., 2002; Bloem and Bhatia, 2004; Bloem et al., 1996) , it may offer significant improvements to anxiety and emotional processing deficits in PD (Witjas et al., 2002; Maricle et al., 1995a,b; Tessitore et al., 2002) . Therefore, future studies need to include PD patients both ON medication (ideally after a supramaximal levodopa dose, to ensure an optimal and consistent ON phase throughout the experiment) and OFF medication, in order to ascertain the basal ganglia's role in mediating anxiety-related changes in postural control.
Another limitation of the study was that subjects were excluded on the basis of having a history of anxiety disorders, extreme fear of heights, and/or treatment with anti-anxiety medications. The exclusion of those with anxiety disorders and extreme fear of heights was justified on ethical grounds, to avoid placing patients in threatening conditions that could potentially trigger an anxiety attack or phobic reactions. Subjects taking anti-anxiety medication were excluded for methodological reasons as the medication would likely mask any normal anxiety response to the threat of standing on elevated surfaces. However, we realize that this may have impacted our ability to detect differences between groups, and thus, limited any insight into how the basal ganglia may contribute to anxiety-related effects on postural control. It also limits the ability to generalize the current results to the significant number of patients that suffer from clinical and non-clinical anxiety (Stein et al., 1990; Menza et al., 1993; Aarsland et al., 1999; Kulisevsky et al., 2008) . Therefore, further studies should be done to investigate the influence of anxiety and fear on the postural control of PD patients with known anxiety.
A third limitation is that subjects included in this study were relatively well functioning and showed little evidence of postural deficits during clinical examination and fall history. Although nine of the subjects scored abnormally on the clinical postural test, only two had a history of falls, and both of these subjects responded to the changes in height in the same way as the others. Irrespectively, there are still questions regarding whether subjects with more severe motor and postural deficits would show greater differences in postural control compared to controls, and whether they may respond differently to changes in postural threat.
No main effect of PD on postural control measures
In this study, no significant differences were observed between PD patients and controls in terms of amplitude, frequency, or mean position of COP. This result provides further evidence in support of prior studies that have reported no significant differences in COP measures between PD patients and controls during quiet stance (Schi- eppati and Nardone, 1991; Termoz et al., 2008) . These findings contradict others that have reported the effects of PD on COP amplitude (Horak et al., 1992; Mitchell et al., 1995; Contin et al., 1996; Rocchi et al., 2002; Maurer et al., 2003; Nardone and Schieppati, 2006; Błaszczyk et al., 2007) , frequency, (Rocchi et al., 2002; Maurer et al., 2003) , or mean position of COP (Schieppati and Nardone, 1991; Błaszczyk et al., 2007; Termoz et al., 2008) . Differences between the current study and previous work are not likely related to differences in disease severity of patients, as the UPDRS and Hoehn and Yahr scores were similar to those reported in prior studies. Therefore, likely sources of variation may be attributed to differences in experimental protocols, including instruction, sample duration and analysis, timing and dose of medication, or the presence of other co-morbidities (including anxiety symptoms).
Relevance of the findings to a clinical setting
Despite the limitations described above, the results of this study show that the postural control of quiet standing in healthy elderly control subjects and PD patients on medication is equally susceptible to the influence of anxiety. Given the high prevalence of anxiety and fear of falling in PD patients, it should be considered a factor when interpreting balance assessments in this patient population. This should be done especially if comparisons are made with healthy elderly control subjects, in whom the prevalence of anxiety and fear is lower than in PD patients.
Evidence that sources of anxiety can influence balance in older healthy adults (Carpenter et al., 1999 (Carpenter et al., , 2006 Brown et al., 2006; Geh et al., 2010) , as well as PD patients, also highlights the need for clinicians to account for other potential sources of anxiety or fear that could either mask or mimic a potential balance deficit. Potential sources of anxiety include anxiogenic or anxiolytic medications, clinical or non-clinical anxiety disorders, and social anxiety related to the prospect of being negatively evaluated by the clinician (Geh et al., 2010) .
CONCLUSION
In summary, the results of this study indicate that static balance in PD patients and healthy elderly controls is equally susceptible to the influence of anxiety. Future studies could further address this issue by including more severely affected patients both ON and OFF dopaminergic medication, more anxious patients, or by using dynamic measures of balance. NWO VIDI grant (# 016.076. 352) .
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